One of the two downregulated genes, IGFBP5 (insulin-like growth factor binding protein 5), is a key regulator of osteogenic differentiation, and agents that antagonize its expression have been shown to promote osteoporosis (49, 50). Here, IGFBP5 is linked to osteoporosis.